Stocks
Heron Therapeutics (HRTX) Net margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Net margin, % | ? | -255.6% | -169.1% | -87.0% | -9.41% | -13.0% | -20.5% | ||
| Changes by years, y/y, % | +1pp | +87pp | +82pp | +78pp | -4pp | -44.9% | |||
Heron Therapeutics. Net margin, %
Heron Therapeutics. Net margin, changes, pp
Heron Therapeutics (HRTX) Net margin US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| Net margin, % | ? | 6.77% | -6.40% | -45.8% | -7.28% | -23.4% | -20.5% | |
| Changes by years, y/y, % | +16pp | +19pp | -31pp | -16pp | -30pp | |||
| Changes by quarters, q/q, % | -2pp | -13pp | -39pp | +39pp | -16pp | |||
